pharmaceutical distributor
Scope
Date
~
-
Bio & Pharma
Spectrum to push back launch date of Hanmi-developed drug Poziotinib
Hanmi Pharmaceutical Co. announced Friday that California-based Spectrum Pharmaceuticals Inc. received a Complete Response Letter (CRL) from the US ...
Nov 25, 2022 (Gmt+09:00)
-
Bio & Pharma
JW Pharmaceutical relocates US research center from Seattle to Boston
JW Pharmaceutical announced on Wednesday that it has relocated its US research center to Boston from San Diego. JW Theriac was first establishe...
Nov 23, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean biotech firms fold COVID-19 therapeutics development businesses
A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...
Jul 04, 2022 (Gmt+09:00)
-
Entertainment
Korea's key movie firm to push content production M&As
In recent years, the content creation industry in South Korea has been a key investment sector for local investment banks. Some major content produc...
May 16, 2022 (Gmt+09:00)
language -
Entertainment
HBO, Paramount to enter Korea via local OTT players
Two US streaming platforms HBO Max and Paramount Plus will be launching South Korean services this year via domestic over-the-top (OTT) players in a...
May 11, 2022 (Gmt+09:00)
-
Bio & Pharma
SK's biotech bets step closer to commercialization
Biotechnology startups in Europe, backed by South Korea's SK Inc., are speeding up their development of next-generation drug candidates by joining h...
Apr 15, 2022 (Gmt+09:00)
-
Bio & Pharma
FDA to review Hanmi Pharmaceutical’s Rolontis for marketing approval
The US Food and Drug Administration has begun reviewing a medicine developed by South Korea’s Hanmi Pharmaceutical Co. for marketing authoriza...
Apr 13, 2022 (Gmt+09:00)
-
Content platforms
Korea's major fashion firms rush to embrace content marketing
Major South Korean fashion companies are speeding up their investment in content startups. F&F Holdings, the distributor of the US outdoor brand...
Mar 25, 2022 (Gmt+09:00)
-
Bio
K-bio's out-licensing this year reaches $9.3 bn
Overseas technology transfers from South Korean biotechs and pharmaceutical manufacturers this year have exceeded 11 trillion won ($9.3 billion), al...
Nov 18, 2021 (Gmt+09:00)
language -
Biotech
Korea’s bio startup Voronoi inks $324 million deal with Brickell Biotech
Voronoi Inc., a South Korean biotechnology startup, has clinched a $324 million deal to grant Brickell Biotech, a US clinical-stage pharmaceutical f...
Sep 02, 2021 (Gmt+09:00)
language -
Pharmaceuticals
Daewoong Pharmaceutical aims to top $4 bn in sales by 2027
South Korea-based Daewoong Pharmaceutical Co. is hoping to achieve 5 trillion won ($4.4 billion) in sales by 2027, meaning that the company aims to ...
Aug 04, 2021 (Gmt+09:00)
language